Clinical Trial Update: Spironolactone Therapy in Chronic Stable Right HF Trial [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing spironolactone therapy in patients with chronic stable right heart failure, including those with pulmonary arterial hypertens…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Arterial Hypertension
• Pulmonary Arterial Hypertension
• Pulmonary Hypertension
• Right Ventricular Cardiomyopathy
• Right-sided Heart Failure

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Chronic Right-Sided Heart Failure, Pulmonary Arterial Hypertension | Phase 4 | Status: COMPLETED